Cleared Traditional

K903965 - STATPAL BLOOD GAS MONITORING SYSTEM

K903965 is an FDA 510(k) clearance for STATPAL BLOOD GAS MONITORING SYSTEM, manufactured by Ppg Industries, Inc.. The device is a Class 2 Chemistry device with product code CHL cleared through the Traditional 510(k) pathway after a 120-day FDA review.

K903965 · Ppg Industries, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1990
Decision
120d
Days
Class 2
Risk

K903965 is an FDA 510(k) clearance for the STATPAL BLOOD GAS MONITORING SYSTEM. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Ppg Industries, Inc. (La Jolla, US). The FDA issued a Cleared decision on December 26, 1990 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Ppg Industries, Inc. devices

FDA 510(k) Submission Details - K903965

510(k) Number K903965 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 1990
Decision Date December 26, 1990
Days to Decision 120 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 88d · This submission: 120d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CHL Device Classification - Class 2, Special Controls

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 152
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K903965.
ABL505 BLOOD GAS & ELECTROLYTE SYSTEM
K914166 · Radiometer America, Inc. · Jan 1992
STAT PAL SENSYR SYRINGE ASSEMBLY FOR USE W/STATPAL
K914560 · Ppg Industries, Inc. · Nov 1991
IL BG3 SYST, MODEL 1420, BLOOD GAS & PH TEST SYST
K913927 · Instrumentation Laboratory CO · Oct 1991
ABL510 BLOOD GAS SYSTEM
K904513 · Radiometer America, Inc. · Dec 1990
CIBA CORNING MODEL 238 PH/ BLOOD GAS ANALYZER
K904188 · Ciba Corning Diagnostics Corp. · Sep 1990
BLOOD GASES/PC02, PO2 ANALYSIS PRODUCTS
K902267 · Phoenix Diagnostics, Inc. · Jun 1990